Andrew Green (Drew)

Andrew (Drew) Green has a diverse and extensive work experience spanning over several industries. Andrew (Drew)'smost recent position is as the Vice President of Regulatory Affairs at Artivion, Inc. which they began in March 2021. Prior to this, they held the role of EVP, Regulatory and Scientific Affairs at Aziyo Biologics, Inc. from May 2019 to May 2020. Andrew (Drew) also served as the EVP and General Manager of Cardiovascular Products and Chief Business Officer at Aziyo Biologics.

Before joining Aziyo Biologics, Andrew Green worked at CorMatrix Cardiovascular, Inc. where they held various roles including CEO, President & COO, Executive Vice President of Operations, and VP, Regulatory, Quality, and Clinical Development. Andrew (Drew) was employed at CorMatrix Cardiovascular from 2013 to 2017.

Prior to that, Andrew Green worked at Halscion as the VP Regulatory and Clinical from December 2009 to July 2013. Andrew (Drew) also held the position of VP, Scientific Affairs at USHIFU, LLC from December 2008 to December 2009. Andrew Green started their career at NeoMedica LLC and Isonett LLC, where they served as a Principal from March 2005 to December 2009.

Other notable positions they held include CEO of Oncologix Corporation from July 2006 to December 2007, and VP at Novoste Corporation from 1996 to 2005. Andrew (Drew) began their professional career as a Combat Medic in the US Army from March 1987 to March 1993. Andrew (Drew) also worked as a Scientific Reviewer at the FDA from March 1993 to August 1996.

Andrew Green brings a wealth of experience and expertise in regulatory affairs, scientific affairs, and executive management roles to their current position at Artivion, Inc.

Drew Green pursued their Bachelor of Science degree in Biological Sciences from Clemson University from 1987 to 1991. Following this, they continued their education at Clemson University and obtained their Master of Science degree in Bioengineering from 1991 to 1993.